ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,599Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 315

$863K Total Retail Price of All Prescriptions

Rank: 18 out of 315

557 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 557 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 557 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

4% of this provider’s 11,646 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 948 600 1 1
LISINOPRIL 678 463 2 3
METOPROLOL SUCCINATE 660 452 3 13
LEVOTHYROXINE SODIUM 462 318 4 6
AMLODIPINE BESYLATE 452 351 5 2
METFORMIN HCL 423 269 6 7
OMEPRAZOLE 402 280 7 9
ATORVASTATIN CALCIUM 398 345 8 5
PREDNISONE 375 253 9 41
LOSARTAN POTASSIUM 266 215 10 4
TRIAMCINOLONE ACETONIDE 252 187 11 62
FUROSEMIDE 243 182 12 15
ALENDRONATE SODIUM 213 171 13 12
HYDROXYZINE HCL 205 122 R 14 105
ALLOPURINOL 203 130 15 14
IBUPROFEN 195 120 16 89
AMOX TR-POTASSIUM CLAVULANATE 192 144 17 147
GLYBURIDE 187 144 R 18 49
METOPROLOL TARTRATE 186 136 19 18
DONEPEZIL HCL 186 186 19 28
CEPHALEXIN 172 106 21 109
AMLODIPINE BESYLATE-BENAZEPRIL 171 105 22 26
NAMENDA 160 160 23 38
HYDROCODONE-ACETAMINOPHEN 159 70 S3 24 19
GABAPENTIN 156 105 25 37
GLIPIZIDE 152 98 26 30
POTASSIUM CHLORIDE 150 104 27 36
CIPROFLOXACIN HCL 140 103 28 58
PANTOPRAZOLE SODIUM 140 126 28 35
CARVEDILOL 139 76 30 22
WARFARIN SODIUM 134 92 31 20
LOSARTAN-HYDROCHLOROTHIAZIDE 129 118 32 17
PRAVASTATIN SODIUM 124 98 33 10
TAMSULOSIN HCL 124 99 33 21
DIOVAN 117 84 35 27
ACTOS 116 94 36 78
CELEBREX 112 110 37 34
CLOPIDOGREL 112 101 37 25
ADVAIR DISKUS 109 87 39 46
LOVASTATIN 99 63 40 8
DIOVAN HCT 97 87 41 56
MUPIROCIN 97 54 41 110
MECLIZINE HCL 96 91 43 81
MIRTAZAPINE 94 54 44 68
CRESTOR 92 75 45 24
PLAVIX 91 79 46 40
COLCRYS 88 64 47 85
DIGOXIN 87 76 48 45
GLIPIZIDE ER 85 84 49 55
ATENOLOL 83 77 50 11
CLOBETASOL PROPIONATE 83 56 50 82
NIFEDIAC CC 81 53 52 97
LACTULOSE 79 48 53 115
GLYBURIDE-METFORMIN HCL 78 73 R 54 87
GEMFIBROZIL 77 56 55 70
CITALOPRAM HBR 75 43 56 72
TRIAMTERENE-HCTZ 75 53 56 71
NIFEDIPINE ER 75 41 56 67
METFORMIN HCL ER 73 52 59 33
PROAIR HFA 70 44 60 52
LIPITOR 68 58 61 44
FELODIPINE ER 67 49 62 23
CYMBALTA 66 49 63 165
NEXIUM 66 48 63 54
TRAZODONE HCL 66 22 63 93
SPIRONOLACTONE 66 44 63 95
ZOLPIDEM TARTRATE 65 23 67 29
LYRICA 64 51 68 126
PEN NEEDLE 64 54 68 91
HYDROCHLOROTHIAZIDE 62 48 70 16
RISPERIDONE 60 59 71 148
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 26 72 149
TRICOR 58 37 73 130
RANITIDINE HCL 57 21 74 42
CICLOPIROX 57 46 74 317
LANTUS 55 19 76 113
AVODART 55 55 76 113
BENZTROPINE MESYLATE 55 43 R 76 319
SERTRALINE HCL 55 48 76 100
HYDRALAZINE HCL 53 20 80 98
KETOCONAZOLE 52 37 81 193
CALCIUM ACETATE 50 20 82 332
LANTUS SOLOSTAR 50 47 82 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.